Acquired Hemophilia A Successfully Treated with Rituximab

Acquired hemophilia A (AHA) is a rare bleeding disorder due to the development of specific autoantibodies against factor VIII. The anti-CD20 monoclonal antibody Rituximab has been proven to be effective in obtaining a long-term suppression of inhibitors of AHA, besides other immunosuppressive standa...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mediterr J Hematol Infect Dis
Главные авторы: D’Arena, Giovanni, Grandone, Elvira, Di Minno, Matteo Nicola Dario, Musto, Pellegrino, Di Minno, Giovanni
Формат: Artigo
Язык:Inglês
Опубликовано: Università Cattolica del Sacro Cuore 2015
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4344169/
https://ncbi.nlm.nih.gov/pubmed/25745551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2015.024
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы